These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

627 related articles for article (PubMed ID: 7511134)

  • 21. Diurnal variation of sex hormone binding globulin and insulin-like growth factor binding protein-1 in women with polycystic ovary syndrome.
    Hamilton-Fairley D; White D; Griffiths M; Anyaoku V; Koistinen R; Seppälä M; Franks S
    Clin Endocrinol (Oxf); 1995 Aug; 43(2):159-65. PubMed ID: 7554310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Growth hormone secretion is impaired but not related to insulin sensitivity in non-obese patients with polycystic ovary syndrome.
    de Boer JA; Lambalk CB; Hendriks HH; van Aken C; van der Veen EA; Schoemaker J
    Hum Reprod; 2004 Mar; 19(3):504-9. PubMed ID: 14998943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Massive weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-I levels in obese subjects.
    Rasmussen MH; Hvidberg A; Juul A; Main KM; Gotfredsen A; Skakkebaek NE; Hilsted J; Skakkebae NE
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1407-15. PubMed ID: 7536210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An abnormality of the growth hormone/insulin-like growth factor-I axis in women with polycystic ovary syndrome due to coexistent obesity.
    Slowinska-Srzednicka J; Zgliczynski W; Makowska A; Jeske W; Brzezinska A; Soszynski P; Zgliczynski S
    J Clin Endocrinol Metab; 1992 Jun; 74(6):1432-5. PubMed ID: 1534330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreased sex hormone binding globulin (SHBG) and insulin-like growth factor binding protein (IGFBP-1) in extreme obesity.
    Weaver JU; Holly JM; Kopelman PG; Noonan K; Giadom CG; White N; Virdee S; Wass JA
    Clin Endocrinol (Oxf); 1990 Sep; 33(3):415-22. PubMed ID: 1701370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amplified and orderly growth hormone secretion characterizes lean adolescents with polycystic ovary syndrome.
    Garcia-Rudaz MC; Ropelato MG; Escobar ME; Veldhuis JD; Barontini M
    Eur J Endocrinol; 2002 Aug; 147(2):207-16. PubMed ID: 12153742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of growth hormone in polycystic ovarian syndrome.
    Morales AJ
    Semin Reprod Endocrinol; 1997 May; 15(2):177-82. PubMed ID: 9165661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Levels of growth hormone, insulin-like growth factor-I (IGF-I) and -II, IGF-binding protein-1 and -3, and cortisol in prednisone-treated children with growth retardation after renal transplantation.
    Hokken-Koelega AC; Stijnen T; de Muinck Keizer-Schrama SM; Blum WF; Drop SL
    J Clin Endocrinol Metab; 1993 Oct; 77(4):932-8. PubMed ID: 7691864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of stimulation of 24-hour growth hormone release by hypocaloric diet in obesity.
    Rasmussen MH; Juul A; Kjems LL; Skakkebaek NE; Hilsted J
    J Clin Endocrinol Metab; 1995 Mar; 80(3):796-801. PubMed ID: 7533771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum bioactive and immunoreactive luteinizing hormone and follicle-stimulating hormone levels in women with cycle abnormalities, with or without polycystic ovarian disease.
    Fauser BC; Pache TD; Lamberts SW; Hop WC; de Jong FH; Dahl KD
    J Clin Endocrinol Metab; 1991 Oct; 73(4):811-7. PubMed ID: 1909705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship of plasma adiponectin with sex hormone and insulin-like growth factor levels.
    Tworoger SS; Mantzoros C; Hankinson SE
    Obesity (Silver Spring); 2007 Sep; 15(9):2217-24. PubMed ID: 17890489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum levels of insulin-like growth factor binding protein-1 and ovulatory responses to clomiphene citrate in women with polycystic ovarian disease.
    Tiitinen AE; Laatikainen TJ; Seppälä MT
    Fertil Steril; 1993 Jul; 60(1):58-62. PubMed ID: 7685718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical features and circulating gonadotropin, insulin, and androgen interactions in women with polycystic ovarian disease.
    Anttila L; Ding YQ; Ruutiainen K; Erkkola R; Irjala K; Huhtaniemi I
    Fertil Steril; 1991 Jun; 55(6):1057-61. PubMed ID: 1903726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 125I-insulin binding to circulating erythrocytes, monocytes and cultured fibroblasts in non-obese patients with polycystic ovarian disease.
    Mahabeer S; Naidoo C; Norman RJ; Jialal I; Govender T; Haneef R; Dunn R; Joubert SM
    Diabetes Res; 1990 Mar; 13(3):139-44. PubMed ID: 2128692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin resistance and overweight-obese women with polycystic ovary syndrome.
    Bhattacharya SM
    Gynecol Endocrinol; 2010 May; 26(5):344-7. PubMed ID: 19903118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of obesity and chronic hyperinsulinemia on gonadotropin release and gonadal steroid secretion in the polycystic ovary syndrome.
    Dunaif A; Mandeli J; Fluhr H; Dobrjansky A
    J Clin Endocrinol Metab; 1988 Jan; 66(1):131-9. PubMed ID: 2961783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GH release after GHRH plus arginine administration in obese and overweight women with polycystic ovary syndrome.
    Orio F; Palomba S; Colao A; Russo T; Dentico C; Tauchmanovà L; Savastano S; Nappi C; Sultan C; Zullo F; Lombardi G
    J Endocrinol Invest; 2003 Feb; 26(2):117-22. PubMed ID: 12739737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin regulation of insulin-like growth factor binding protein-1 in obese and nonobese humans.
    Conover CA; Lee PD; Kanaley JA; Clarkson JT; Jensen MD
    J Clin Endocrinol Metab; 1992 Jun; 74(6):1355-60. PubMed ID: 1375600
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metastin levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome.
    Yilmaz SA; Kerimoglu OS; Pekin AT; Incesu F; Dogan NU; Celik C; Unlu A
    Eur J Obstet Gynecol Reprod Biol; 2014 Sep; 180():56-60. PubMed ID: 25020276
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth hormone bioactivity in girls with Turner's syndrome: correlation with insulin-like growth factor I.
    Foster CM; Borondy M; Markovs ME; Hopwood NJ; Kletter GB; Beitins IZ
    Pediatr Res; 1994 Feb; 35(2):218-22. PubMed ID: 7513079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.